AlmaCann spends great effort to make the best possible products to help physicians provide the best possible cannabis treatment for their patients. To achieve this, we spent 3 years researching patient needs, physicians’ reservations, regulatory requirements and technological challenges before we felt ready to construct the ultimate facility. We are looking to innovate the cannabis industry, mainly on the cultivation side, to deliver a stabilized product.
Our R&D department is working to develop new strains and cultivation techniques to meet the rigorous expectations of plant-based medicines. Our unique genetics are being bread to keep the plants healthy and stable in flexible environmental conditions. Our cultivation facility will become a data collection hub where we plan to use machine learning and rigorous testing for continuous improvement.
Continuous
operation using standard
operating procedures helps
us ensure that both
cultivation and processing
are done with the great care
for the patients and product.
Our secure processing
facility uses pharmaceutical
grade equipment to ensure
high quality manufacturing
in an EU-GMP environment.